Cipta Sarana Medika Tbk. vs Intanwijaya Internasional Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 2.88M 24h volume), while Intanwijaya Internasional Tbk trades at Rp670 (market cap 140.17B, 600 24h volume). The key difference: Cipta Sarana Medika Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (2.88M versus 600). Which is the better fit depends on your goals.
| DKHH | INCI | |
|---|---|---|
Market Cap | 163.22B | 140.17B |
Volume | 2.88M | 600 |
Lot | 28.82K | 6 |
Turnover | 183.58M | 403K |
Average Price | 63.7 | 671.67 |
Value | 183.58M | 403K |
Indicative Equilibrium Price | 64 | — |
Indicative Equilibrium Volume | 110.6K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.
Read more on INCI →